Stem-cell transplantation (Cerus/Kirin)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameStem-cell transplantation (Cerus/Kirin)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionStem cells modulators
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKirinCerus Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKirinCerus Co
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A